GRCE
GRCE

Grace Therapeutics Inc

NASDAQ · Pharmaceuticals
$3.60
+0.12 (+3.45%)
Analyst Consensus
Strong Buy
8 analysts
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +541.4% upside
Low Target $18.68
Average Target $23.09
High Target $33.94
Current Price $3.60
Current
$3.60
Target
$23.09
$18.68 $23.09 avg $33.94